Skip to main content
SpringerLink
Log in

Integrated Diabetes Care: Coventry and Warwickshire Approach

  • Chapter
  • First Online:
Integrated Diabetes Care

  • 1491 Accesses

Abstract

The rapid increase in the prevalence of diabetes is not abating across the world. The cost burden of managing diabetes and its complications is putting significant strain on healthcare resources worldwide. Increasingly large proportions of patients with diabetes, including those with complications, are managed by primary care. This has resulted in disjointed as well as huge variation in care, even in managed care systems and the National Health Service (NHS) in the UK. Several attempts have been made to manage patients in the community, such as the widely adopted GPwSI (GP with special interest) model in the UK but with no real evidence of its clinical or cost-effectiveness. The data on cardiovascular risk factors has been captured comprehensively since the introduction of quality outcomes framework (QoF) in the UK. However, longitudinal data has not been utilised to proactively identify and improve individualised care due to the lack of joined-up care, particularly the digital integration of data. To address these issues, we designed two separate projects: a cluster randomised trial of intermediate care clinics in diabetes and proactive identification and management of diabetes patients through a novel web-based digital integration of the data from 12 general practices. The cluster-randomised trial was an ambitious attempt and highlighted the difficulties of conducting large scale RCTs with a high number of follow-up rates. It did however show the importance of team-change, need for local champions and proactive case-finding approach to drive improvements in chronic diseases such as diabetes. The innovation project showed that proactive case-finding and individualised care plan development is feasible utilising existing resources if technology is adopted and used. For this to be sustainable, upskilling of the primary care with tailor made educational workshops, acceptance by the commissioners and providers in the healthcare economy are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Federation ID. IDF diabetes atlas. 6th ed. Brussels: International Diabetes Federation; 2013.

    Google Scholar 

  2. Guariguata L. Tackling the global epidemic – new estimates from the IDF diabetes atlas update for 2012. Diabetes Voice. 2012;57(3):12–5.

    Google Scholar 

  3. Ham C, York N, Sutch S, Shaw R. Hospital bed utilisation in the NHS, Kaiser Permanente, and the US Medicare programme: analysis of routine data. BMJ. 2003;327(7426):1257.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Murphy E. Case management and community matrons for long term conditions. BMJ. 2004;329(7477):1251–2.

    Article  PubMed  PubMed Central  Google Scholar 

  5. The NHS Information Centre. National diabetes audit executive summary 2009–2010.

    Google Scholar 

  6. Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care? J R Soc Med. 2000;93:183–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Millett C, Gray J, Saxena S, Netuveli G, Khunti K, Majeed A. Ethnic disparities in diabetes management and pay-for-performance in the UK: the Wandsworth Prospective Diabetes Study. PLoS Med. 2007;4(6):e191.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N. Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ. 2009;338:b1870.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, Zhang F, et al. Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ. 2011;342:d108.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Millett C, Saxena S, Ng A, Mainous 3rd A, Majeed A. Socio-economic status, ethnicity and diabetes management: an analysis of time trends using the health survey for England. J Publ Health (Oxf). 2007;29(4):413–9.

    Article  Google Scholar 

  11. Gulliford MC, Ashworth M, Robotham D, Mohiddin A. Achievement of metabolic targets for diabetes by English primary care practices under a new system of incentives. Diabet Med. 2007;24(5):505–11.

    Article  CAS  PubMed  Google Scholar 

  12. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ. 2008;336(7642):491–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Khunti K, Davies M. Glycaemic goals in patients with type 2 diabetes: current status, challenges and recent advances. Diabetes Obes Metab. 2010;12:474–84.

    Article  CAS  PubMed  Google Scholar 

  14. Nocon A, Rhodes PJ, Wright JP, Eastham J, Williams DR, Harrison SR, et al. Specialist general practitioners and diabetes clinics in primary care: a qualitative and descriptive evaluation. Diabet Med: J Br Diabet Assoc. 2004;21(1):32–8.

    Article  CAS  Google Scholar 

  15. Halfyard C, McGowan D, Whyte M, Gayle C. Diabetes rapid access clinic: a bridge between primary and secondary care (Diabetes UK poster presentation). Diabet Med. 2010;27 Suppl 1:137.

    Google Scholar 

  16. Sharp PS. Glycaemic outcomes following discharge from an intermediate care diabetes clinic. Pract Diabetes Int. 2010;27(2):53–4.

    Article  Google Scholar 

  17. Health in Wales. Cardiff CCM demonstrator model for diabetes intermediate care clinics-progress underway 2010 [cited 2011 29 August]. Available from: http://www.wales.nhs.uk/news/16399.

  18. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833):2252–61.

    Article  PubMed  Google Scholar 

  19. Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control. JAMA J Am Med Assoc. 2006;296(4):427–40.

    Article  CAS  Google Scholar 

  20. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–93.

    Article  PubMed  Google Scholar 

  21. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.

    Article  CAS  PubMed  Google Scholar 

  22. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359(15):1565–76.

    Article  CAS  PubMed  Google Scholar 

  23. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765–72.

    Article  CAS  PubMed  Google Scholar 

  24. Ahroni JH, Boyko EJ, Davignon DR, Pecoraro RE. The health and functional status of veterans with diabetes. Diabetes Care. 1994;17(4):318–21.

    Article  CAS  PubMed  Google Scholar 

  25. Van der Does FE, De Neeling JN, Snoek FJ, Kostense PJ, Grootenhuis PA, Bouter LM, et al. Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care. 1996;19(3):204–10.

    Article  PubMed  Google Scholar 

  26. Papanas N, Tsapas A, Papatheodorou K, Papazoglou D, Bekiari E, Sariganni M, et al. Glycaemic control is correlated with well-being index (WHO-5) in subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2010;118(6):364–7.

    Article  CAS  PubMed  Google Scholar 

  27. Gray A, Clarke P, Farmer A, Holman R. Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63). BMJ. 2002;325(7369):860.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Armstrong N, Baines D, Baker R, Crossman R, Davies M, Hardy A, et al. A cluster randomised controlled trial of the effectiveness and cost-effectiveness of Intermediate Care Clinics for Diabetes (ICCD): study protocol for a randomised controlled trial. Trials. 2012;13:164.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wilson A, O’Hare JP, Hardy A, Raymond N, Szczepura A, Crossman R, et al. Evaluation of the clinical and cost effectiveness of intermediate care clinics for diabetes (ICCD): a multicentre cluster randomised controlled trial. PLoS One. 2014;9(4):e93964.

    Article  PubMed  PubMed Central  Google Scholar 

  30. The Diabetes Trials Unit – Oxford. UKPDS risk engine: home page. 2010 [cited 2010 3 February]. Available from: http://www.dtu.ox.ac.uk/riskengine/index.php.

  31. The Euroqol Group. EQ-5D user guide: a measure of health-related quality of life developed by the EuroQol Group. The Netherlands: EuroQol Business Management; 1995.

    Google Scholar 

  32. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care. 1997;20(5):760–6.

    Article  CAS  PubMed  Google Scholar 

  33. Gulliford MC, Naithani S, Morgan M. Continuity of care and intermediate outcomes of type 2 diabetes mellitus. Fam Pract. 2007;24(3):245–51.

    Article  PubMed  Google Scholar 

  34. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.

    Google Scholar 

  35. Hippisley-Cox J, O’Hanlon S, Coupland C. Association of deprivation, ethnicity, and sex with quality indicators for diabetes: population based survey of 53,000 patients in primary care. BMJ. 2004;329(7477):1267–9.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Kinmonth AL, Woodcock A, Griffin S, Spiegal N, Campbell MJ. Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. BMJ. 1998;317:1202–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Bellary S, O’Hare JP, Raymond NT, Gumber A, Mughal S, Szczepura A, et al. Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet. 2008;371(9626):1769–76.

    Article  CAS  PubMed  Google Scholar 

  38. Miyamoto JM, Eraker SA. Parameter estimates for a QALY utility model. Med Decis Making Int J Soc Med Decis Making. 1985;5(2):191–213.

    Article  CAS  Google Scholar 

  39. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ. 2004;13(12):1203–10.

    Article  PubMed  Google Scholar 

  40. Baker R, Chilton S, Donaldson C, Jones-Lee M, Lancsar E, Mason H, et al. Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE. Health Econ Policy Law. 2011;6(4):435–47.

    Article  PubMed  Google Scholar 

  41. Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ. 2011;342:d1548.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Brown J. Diabetes manager. (http://www.diabetesmanager.org.uk). 2010.

  43. Brown J. Eclipse. (http://www.eclipsecolutions.org). 2013.

  44. Health and Social Care Information Centre. (2015). Accessed at http://www.hscic.gov.uk on 19 Dec 2015.

  45. Geographies of diversity in Leicestershire; Leicestershire City Council. (2013). Accessed at http://www.ethnicity.ac.uk/.

  46. Getting to Grips with the year of care: a practical guide. (2008). Accessed at http://www.yearofcare.co.uk on 19 Dec 2015.

  47. Think glucose. (2011). Accessed at http://www.institute.nhs.uk/ on 19 Dec 2015.

Download references

Acknowledgements

Authors of this invited book chapter fully acknowledge all the ICCD study group members: Natalie Armstrong, Darrin Baines, Richard Baker, Richard Crossman, Melanie Davies, Ainsley Hardy, Kamlesh Khunti, Sudhesh Kumar, Joseph Paul O’Hare, Neil Raymond, Ponnusamy Saravanan, Nigel Stallard, Ala Szczepura and Andrew Wilson.

Dr Saravanan thanks Dr Julian Brown, Founder of Diabetes Manager & Eclipse systems for providing the system free during the COMBINE for Diabetes innovation programme.

Conflict of Interest

Authors declare no conflict of interest. Although Dr Ponnusamy Saravanan provided feedback regarding the Diabetes Manager system, he was not paid for this service.

Author information

Authors and Affiliations

  1. George Eliot Hospital NHS Trust, Coventry, UK

    Ponnusamy Saravanan & Vinod Patel

  2. Warwick Medical School, The University of Warwick, Coventry, UK

    Ponnusamy Saravanan, Vinod Patel, Joseph Paul O’Hare & Sudhesh Kumar

  3. University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

    Ponnusamy Saravanan, Joseph Paul O’Hare & Sudhesh Kumar

Authors
  1. Ponnusamy Saravanan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinod Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joseph Paul O’Hare
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sudhesh Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ponnusamy Saravanan .

Editor information

Editors and Affiliations

  1. School of Medicine, Western Sydney University, Sydney, New South Wales, Australia

    David Simmons

  2. Health Economist, Konstanz, Germany

    Helmut Wenzel

  3. Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, Florida, USA

    Janice C. Zgibor

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Saravanan, P., Patel, V., O’Hare, J.P., Kumar, S. (2017). Integrated Diabetes Care: Coventry and Warwickshire Approach. In: Simmons, D., Wenzel, H., Zgibor, J. (eds) Integrated Diabetes Care. Springer, Cham. https://doi.org/10.1007/978-3-319-13389-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13389-8_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13388-1

  • Online ISBN: 978-3-319-13389-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation